Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease.
about
Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophreniaThe glial growth factors deficiency and synaptic destabilization hypothesis of schizophreniaEye Movement in Unipolar and Bipolar Depression: A Systematic Review of the LiteratureContribution of nonprimate animal models in understanding the etiology of schizophrenia.The evolution of drug development in schizophrenia: past issues and future opportunities.Biological markers and schizophrenia.A gene-model-free method for linkage analysis of a disease-related-trait based on analysis of proband/sibling pairsThe myelin-pathogenesis puzzle in schizophrenia: a literature review.Biology of chromosome 6.Linkage and associated studies of schizophrenia.Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia.Eye movement dysfunction in schizophrenia: a heritable characteristic for enhancing phenotype definition.Developing therapeutics for schizophrenia and other psychotic disorders.Incorporation of molecular data and redefinition of phenotype: new approaches to genetic epidemiology of bipolar manic depressive illness and schizophrenia.Replication of linkage studies of complex traits: an examination of variation in location estimates.Recent advances in the genetics of schizophrenia.Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes.Biological phenotypes and genetic research on schizophreniaTumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44.Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study.Schizophrenia endophenotypes as treatment targets.Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorderA model of smooth pursuit eye movement deficit associated with the schizophrenia phenotype.Developments in schizophrenia genetics: from linkage to microchips, deletions and duplications.The concept of FDG-PET endophenotype in Alzheimer's disease.Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects.Carbonyl stress in schizophrenia.Toward a modern search for schizophrenia genes.GABBR1 has a HERV-W LTR in its regulatory region--a possible implication for schizophrenia.Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.Linkage of eye movement dysfunction to chromosome 6p in schizophrenia: additional evidence.Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.Human leukocyte antigen-DQB1 alleles are not associated with schizophrenia in Kuwaiti Arabs.Relationship between class I and II HLA antigens in schizophrenia and eye movement disturbances: a preliminary study.Likability's Effect on Interpersonal Motor Coordination: Exploring Natural Gaze Direction.Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.Smooth pursuit and visual scanpaths: Independence of two candidate oculomotor risk markers for schizophrenia.
P2860
Q24612644-5BA12DB8-B483-495E-97F2-F634ACE25F8FQ24798030-5D367D4B-57F7-41F3-ACA2-EAC766B2027DQ26772369-5546F6B3-CD45-4BD0-ADB0-21C401D09FB6Q30474963-7474F84F-A734-4F2B-9151-7575B6267BF0Q30487850-284E436F-5DC0-46E2-B8AC-6D03B8552FACQ30621233-36E78F16-7620-4A7B-84E5-043D0AD1F410Q33232791-CF23A315-FEB7-4419-B5C6-35989F1C9C7CQ33344726-FFB8730A-703D-42F3-84E6-B99A387998D8Q33834697-6454BC05-F7E5-4D2C-AFE7-4E11219B9E57Q33920492-29F57F64-A266-41B0-BA15-D6FC9DD0F061Q33920507-76C086B2-F55C-45EE-8832-2EE219B87C9DQ33920512-697E5322-67FE-48CC-A9D0-E6AF3EAC587EQ33946985-F93F7940-0DF0-4C01-80D2-1E865FFC0BD6Q34060360-10411BE9-1F9B-46D3-A917-BD00356247B8Q34390287-01712D87-FA7E-4681-9987-598CD3AFF33DQ34578115-316ECF21-7BB4-4B35-8CF4-021203EE02DAQ34626424-E83B3D75-E9F6-4D19-B4EB-5F4C8F21A849Q34721909-F22C18A1-D9C1-4752-9FF1-C28015790BE7Q35097752-A78415A8-93A2-45F2-9E06-FCAD02FEFDBAQ35539209-A0DBD795-B4A6-45B3-8770-861EA8C6FDC4Q35828514-2B792F31-69B8-4F99-8DDC-BEE008CD30C7Q36304346-9528FC48-40FC-48AF-A0AD-312531E1E037Q36378213-52AD3093-7061-48BD-8B96-28E10B721A04Q36936347-9979C424-9371-40A6-9428-05BC0AF77308Q37173056-F3E11993-CFE2-4431-944C-F41243CCA465Q37233960-587323E0-F23A-4A95-8BD8-0515D38AEF17Q37832739-72C31D98-02D8-48CE-87D9-2C1D5F0B75A8Q37883153-3BC6BF3E-1069-447A-B671-6E4754612FFAQ38153348-DEFD254B-BDEA-437C-9F0F-818653BDB0B6Q38197348-37F6CA14-4187-4DC2-9FEF-E8FF654CBA97Q38578844-48FFF81B-E189-4B9D-B012-E922EDC9FB0DQ42762837-0C788375-3463-4B27-9E1B-E2F5C401130DQ43775311-51B876D0-2BDF-41EE-8820-BAA771E20A70Q44947663-0AF1536E-D6EE-4446-BEB6-0086431C1461Q45236947-392DB130-A4FE-422D-BF45-13BC68DD5978Q46252561-656DEB7C-9728-4796-95D4-DEB9F8C9B4C1Q46471575-FF9FE6F2-94EB-43D4-A5FC-BA09140914A6Q47132662-60283651-5E98-4643-953D-C745B8F34396Q47153829-F10C0759-14D2-4963-8BE6-B5076300DF83Q50682146-4AB97117-0768-4929-A06C-83FF024CC54F
P2860
Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@en
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@nl
type
label
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@en
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@nl
prefLabel
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@en
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@nl
P2093
P2860
P1476
Eye tracking dysfunction is a ...... ple occurrence of the disease.
@en
P2093
Müller-Myhsok B
Schwinger E
Schürmann M
P2860
P304
P356
10.1002/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R
P577
1996-11-01T00:00:00Z